Lung cancer risk and effective dose coefficients for radon : UNSCEAR review and ICRP conclusions

© 2021 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved..

The United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) has provided a detailed and authoritative update of its reviews of the epidemiology and dosimetry of radon and progeny. Lifetime risk of lung cancer calculated using data for several miner cohorts were 2.4-7.5 × 10-4per working level month (WLM) of radon-222 progeny exposure for a mixed male/female population and 3.0-9.6 × 10-4per WLM for a male population. Dosimetric models gave mean values of effective dose coefficients from radon-222 progeny of 12 mSv per WLM for mines, 16 mSv per WLM for indoor workplaces and 11 mSv per WLM for homes. The lifetime risk coefficient used by the International Commission on Radiological Protection (ICRP) is 5 × 10-4per WLM and it has recently recommended an effective dose coefficient for radon-222 and progeny of 3 mSv per mJ h m-3(about 10 mSv per WLM) for most circumstances of exposure. The ICRP risk and dose coefficients are supported by the UNSCEAR review and provide a clear and firm basis for current international advice and standards for protection from radon. Notwithstanding this evidence and the ICRP advice, UNSCEAR will continue to use a lower value of effective dose coefficient of 5.7 mSv per WLM for assessments of population exposures.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:41

Enthalten in:

Journal of radiological protection : official journal of the Society for Radiological Protection - 41(2021), 2 vom: 01. Juni

Sprache:

Englisch

Beteiligte Personen:

Harrison, J D [VerfasserIn]

Links:

Volltext

Themen:

Air Pollutants, Radioactive
Dose coefficients
ICRP
Journal Article
Lung cancer risk
Q74S4N8N1G
Radon
Radon Daughters
UNSCEAR

Anmerkungen:

Date Completed 31.03.2022

Date Revised 01.04.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1088/1361-6498/abf547

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32378822X